LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. The company is headquartered in Denmark and is wholly owned by the LEO Foundation.
LEO Pharma open its representatives office in Indonesia last year, providing treatment for psoriasis which is far from a well-known disease in Indonesia.
We create for the in-depth media gathering regarding psoriasis, and on the World Psoriasis Day we create Psoriasis exhibition in Grand Indonesia to educate people about Psoriasis, working together with Psoriasis Foundation in Indonesia.